-
388Wire StoriesAPO’s Newest Member Turkiye Hosts 64th Workshop Meeting of Heads of National Productivity Organizations
ANKARA, Turkiye–(BUSINESS WIRE)–#APO–Turkiye, the Asian Productivity Organization’s (APO’s) newest member, generously hosted the 64th Workshop Meeting (WSM) of Heads of National Productivity...
-
1.1KNewsMindHub Academy 與廣州VV ART維維藝術創作合作
MindHub Academy 與廣州VV ART維維藝術創作合作，推出多樣藝術課程，啟發創意新潮流 香港 – Media OutReach – 2023年10月23日 – 在這個充滿活力的城市，一個令人振奮的消息即將在藝術界掀起巨浪。MindHub Academy 和⌈廣州VV ART維維藝術創作 ⌋合作，MindHub Academy是一家致力於提供高質量教育和藝術培訓的機構，而廣州VV ART維維藝術創作是一家充滿活力且經驗豐富的藝術機構。這兩家機構的合作標誌著一個令人振奮的時刻，即將為藝術愛好者、創意靈感迸發者以及創意初學者帶來一場前所未有的藝術之旅。這個令人期待的合作將提供學生們機會參與和諧粉彩課程、沙畫課程，同時也推出襌繞畫課程、流體畫課程、沙畫工作坊、和藝術工作坊等多樣課程。MindHub Academy將重新定義藝術教育，啟發新的潮流，並為每個參與者打開創意的大門。 MindHub Academy選擇來到廣州參加⌈VV ART維維藝術創作...
-
404Wire StoriesCovation Holdings Continues Expansion in Asia Pacific With New Regional Corporate Headquarters
HONG KONG–(BUSINESS WIRE)–Covation Holdings Limited, the global manufacturer of multiple wheeled goods brands, today announced the addition of a new global corporate...
-
393Wire StoriesBerkshire Hathaway Specialty Insurance Names Sami Jaghbir as Underwriting Manager in Queensland
BRISBANE, Australia & BOSTON–(BUSINESS WIRE)–Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has appointed Sami Jaghbir as Underwriting Manager, Queensland. “Sami...
-
495Wire StoriesGroundbreaking EV-302 Trial Significantly Extends Overall Survival and Progression-Free Survival in Patients Treated with PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) in First-Line Advanced Bladder Cancer
– Risk of death was reduced by 53% in patients treated with enfortumab vedotin plus pembrolizumab compared to chemotherapy – – Enfortumab...
-
405Wire StoriesRaludotatug Deruxtecan Continues to Demonstrate Promising Clinical Activity in Patients with Advanced Ovarian Cancer in Early Trial
Encouraging overall response rate of 46% and disease control rate of 98% with a median duration of response of 11.2 months seen...
-
405NewsCorrecting and Replacing: Lighting the Way to the Future: Renowned Brands Unveil Breakthroughs in the World-Renowned Lighting Marketplace
Buyer Registration Link HONG KONG SAR – Media OutReach – 22 October 2023 – Organised by the Hong Kong Trade Development Council...
-
520Wire StoriesDatopotamab Deruxtecan Plus Durvalumab Demonstrated Robust and Durable Tumor Responses in First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer in BEGONIA Phase 1b/2 Trial
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab showed a confirmed objective response rate of 79% Two ongoing phase 3 trials are...
-
480Wire StoriesCHNT Group Showed at The 24th Conference on The Electric Power Supply Industry
XIAMEN, China–(BUSINESS WIRE)–On October 20th, the 24th Conference on The Electric Power Supply Industry kicked off in Xiamen, attended by more than...
-
803Wire StoriesMakeMyTrip Limited to report Fiscal 2024 Second Quarter Financial & Operating Results on October 31, 2023
GURUGRAM, India & NEW YORK–(BUSINESS WIRE)–$MMYT #Fiscal2024–MakeMyTrip Limited (Nasdaq: MMYT) plans to report its fiscal 2024 second quarter financial and operating results...
